Long-Term Follow-up Protocol — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Long-Term Follow-up Protocol — Stella

Home/Dystrophic Epidermolysis Bullosa/

View on ClinicalTrials.gov

Recruiting

Back to Dystrophic Epidermolysis Bullosa trials

Trial locations(3 sites)

United States

Mission Dermatology Center, Rancho Santa Margarita, California

Stanford University, Redwood City, California

Pediatric Skin Research, Coral Gables, Florida

Key details

Sponsor

Krystal Biotech, Inc.

Enrollment target

~50 participants

Started

May 2021

Primary completion

May 2028

Age range

6 Months and older

Last updated June 2021

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.